Monocytes from Pregnant Women with Pre-Eclampsia are Polarized to a M1 Phenotype

American Journal of Reproductive Immunology

Volumn 72, Issue 1, 2014, Pages 5-13

  Medeiros, Leonardo T L ^a   Peraçoli, José C ^a   Bannwart Castro, Camila F ^a   Romão, Mariana ^a   Weel, Ingrid C ^a   Golim, Marjorie A ^a   de Oliveira, Leandro G ^b   Kurokawa, Cilmery S ^a   Medeiros Borges, Vera T ^a   Peraçoli, Maria T S ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Monocyte subsets; Pre eclampsia; Surface receptors

Indexed keywords

CD64 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MONOCYTE; PHENOTYPE; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; SUPERNATANT; ADOLESCENT; CYTOLOGY; IMMUNOLOGY; PREGNANCY; YOUNG ADULT;

ADOLESCENT; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; MONOCYTES; PHENOTYPE; PRE-ECLAMPSIA; PREGNANCY; YOUNG ADULT;

EID: 84902266986     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12222     Document Type: Article

References (46)

1. Sibai B, Dekker G, Kupferminc M: Pre-eclampsia. Lancet 2005; 365:785-799.
2. Unal ER, Robinson CJ, Johnson DD, Chang EY: Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia. Am J Obstet Gynecol 2007; 197:211.e1-211.e4.
3. Walker JJ: Pre-eclampsia. Lancet 2000; 356:1260-1265.
4. ACOG (American College of Obstetricians and Gynecologists). Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Int J Gynaecol Obstet 2002;77:67-75.
5. Von Dadelszen P, Magee LA, Roberts JM: Subclassification of preeclampsia. Hypertens Pregnancy 2003; 22:143-148.
6. Huppertz B: Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008; 51:970-975.
7. Murphy DJ, Stirrat GM: Mortality and morbidity associated with early-onset preeclampsia. Hypertens Pregnancy 2000; 19:221-231.
8. Ness RB, Sibai BM: Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195:40-49.
9. Raymond D, Peterson E: A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv 2011; 66:497-506.
10. Lok CA, Jebbink J, Nieuwland R, Faas MM, Boer K, Sturk A, Van Der Post JA: Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. Am J Reprod Immunol 2009; 61:346-359.
11. Szarka A, Rigó Jr J, Lázár L, Beko G, Molvarec A: Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 2010; 11:59.
12. De Oliveira LG, Saraiva NO, Peraçoli JC, Peraçoli MT, Moron AF, Sass N: sFlt-1 and IP-10 in women with early-onset preeclampsia. Pregnancy Hypert 2011; 1:129-131.
13. Peraçoli MTS, Bannwart CF, Cristofalo R, Medeiros Borges VT, Araújo Costa RA, Witkin SS, Peraçoli JC: Increased reactive oxygen species and tumor necrosis factor-alpha production by monocytes are associated with elevated levels of uric acid in pre-eclamptic women. Am J Reprod Immunol 2011; 66:460-467.
14. Giorgi VSI, Peraçoli JC, Peraçoli MTS, Bannwart-Castro C: Silibinin modulates NF-kB pathway and proinflammatory cytokines in mononuclear cells of preeclamptic women. J Reprod Immunol 2012; 95:67-72.
15. Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 2005; 308:1592-1594.
16. Brewster JA, Orsi NM, Gopichandran N, Ekbote UV, Cadogan E, Walker JJ: Host inflammatory response profiling in preeclampsia using an in vitro whole blood stimulation model. Hypertens Pregnancy 2008; 27:1-16.
17. Oian P, Omsjø I, Maltau JM, Osterud B: Increased sensitivity to thromboplastin synthesis in blood monocytes from pre-eclamptic patients. Br J Obstet Gynaecol 1985; 92:511-517.
18. Borzychowski AM, Sargent IL, Redman CW: Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 2006; 11:309-316.
19. Sharma D, Singh A, Trivedi SS, Bhattacharjee J: Role of endothelin and inflammatory cytokines in pre-eclampsia - A pilot North Indian study. Am J Reprod Immunol 2010; 65:428-432.
20. Peraçoli JC, Rudge MVC, Peraçoli MT: Tumor necrosis factor-alpha in gestation and puerperium of women with gestational hypertension and pre-eclampsia. Am J Reprod Immunol 2007; 57:177-185.
21. Cristofalo R, Bannwart-Castro CF, Magalhães CG, Borges VT, Peraçoli JC, Witkin SS, Peraçoli MT: Silibinin attenuates oxidative metabolism and cytokine production by monocytes from preeclamptic women. Free Radic Res 2013; 47:268-275.
22. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25:677-686.
23. Martinez FO, Sica A, Mantovani A, Locati M: Macrophage activation and polarization. Front Biosci 2008; 13:453-461.
24. Gordon S: Martinez FO: alternative activation of macrophages: mechanism and functions. Immunity 2010; 32:593-604.
25. Zhou D, Huang C, Lin Z, Zhan S, Kong L, Fang C, Li J: Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal 2014; 26:192-197.
26. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P, Mantovani A: Macrophage polarization in tumour progression. Semin Cancer Biol 2008; 18:349-355.
27. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK: Identification of the haemoglobin scavenger receptor. Nature 2001; 409:198-201.
28. Zuwala-Jagiello J: Haemoglobin scavenger receptor: function in relation to disease. Acta Biochim Pol 2006; 53:257-268.
29. Porcheray F, Viaud S, Rimaniol AC, Léone C, Samah B, Dereuddre-Bosquet N, Dormont D, Gras G: Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 2005; 142:481-489.
30. Bouhlel MA, Derudas B, Rigamonti E, Dièvart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi G: PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007; 6:137-143.
31. Groselj-Grenc M, Ihan A, Derganc M: Neutrophil and monocyte CD64 and CD163 expression in critically ill neonates and children with sepsis: comparison of fluorescence intensities and calculated indexes. Mediators Inflamm 2008; 2008:202646.
32. Babu S, Kumaraswami V, Nutman TB: Alternatively activated and immunoregulatory monocytes in human filarial infections. J Infect Dis 2009; 199:1827-1837.
33. Satoh N, Shimatsu A, Himeno A, Sasaki Y, Yamakage H, Yamada K, Suganami T, Ogawa Y: Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone. Diabetes Care 2010; 33:e7.
34. Lovren F, Pan Y, Quan A, Szmitko PE, Singh KK, Shukla PC, Gupta M, Chan L, Al-Omran M, Teoh H, Verma S: Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. Am J Physiol Heart Circ Physiol 2010; 299:H656-663.
35. Pena OM, Pistolic J, Raj D, Fjell CD, Hancock RE: Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J Immunol 2011; 186:7243-7254.
36. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (NHBPEP). Report of national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
37. Li CY, Lam KW, Yam LT: Esterases in human leukocytes. J Histochem Cytochem 1973; 21:1-12.
38. Reis ZS, Lage EM, Teixeira PG, Porto LB, Guedes LR, Oliveira EC, Cabral AC: Early-onset preeclampsia: is it a better classification for maternal and perinatal outcomes? Rev Bras Ginecol Obstet 2010; 32:584-590.
39. Sakai M, Shiozaki A, Sasaki Y, Yoneda S, Saito S: The ratio of interleukin (IL)-18 to IL-12 secreted by peripheral blood mononuclear cells is increased in normal pregnant subjects and decreased in pre-eclamptic patients. J Reprod Immunol 2004; 61:133-143.
40. Sakai M, Tsuda H, Tanebe K, Sasaki Y, Saito S: Interleukin-12 secretion by peripheral blood mononuclear cells is decreased in normal pregnant subjects and increased in preeclamptic patients. Am J Reprod Immunol 2002; 47:91-97.
41. Peraçoli JC, Bannwart-Castro CF, Romao M, Weel IC, Ribeiro VR, Borges VT, Rudge MV, Witkin SS, Peraçoli MT: High levels of heat shock protein 70 are associated with pro-inflammatory cytokines and may differentiate early- from late-onset preeclampsia. J Reprod Immunol 2013; 100:129-134.
42. Barut F, Barut A, Dogan Gun B, Kandemir NO, Aktunc E, Harma M, Harma MI, Ozdamar SO: Expression of heat shock protein 70 and endothelial nitric oxide synthase in placental tissue of preeclamptic and intrauterine growth-restricted pregnancies. Pathol Res Pract 2010; 206:651-656.
43. Molvarec A, Szarka A, Walentin S, Beko G, Karádi I, Prohászka Z, Rigó J Jr: Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia. Clin Chim Acta 2011; 412:1957-1962.
44. Al-Ofi E, Coffelt SB, Anumba DO: Monocyte subpopulations from pre-eclamptic patients are abnormally skewed and exhibit exaggerated responses to toll-like receptor ligands. PLoS ONE 2012; 7:e42217.
45. Xie F, Turvey SE, Williams MA, Mor G, von Dadelszen P: Toll-like receptor signaling and pre-eclampsia. Am J Reprod Immunol 2010; 63:7-16.
46. Luppi P, Deloia JA: Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 2006; 118:268-275.